加载中
NASDAQHealthcareMedical - Diagnostics & Research
最新数据
US$13.22
−US$2.56 · -16.22%
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome's first commercial-stage test, SimpleScreen CRC for colorectal cancer, is under review by the U.S. Food and Drug Administration (FDA).
收盘时
US$13.22
−US$2.56 · -16.22%
盘后
US$13.22
US$0.00 · 0.00%
10月12日 19:49 ET
盘中时间采用ET。市场数据可能有所延迟。
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome's first commercial-stage test, SimpleScreen CRC for colorectal cancer, is under review by the U.S. Food and Drug Administration (FDA).
日内区间
当前US$13.22
52周区间
当前US$13.22
盘中时间采用ET。市场数据可能有所延迟。
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome's first commercial-stage test, SimpleScreen CRC for colorectal cancer, is under review by the U.S. Food and Drug Administration (FDA).
日内区间
当前US$13.22
52周区间
当前US$13.22
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$18.25
上涨空间 38.05%报告持有此股票敞口的交易所交易基金。
ARK Genomic Revolution ETFARKG1489.44万0.70%15.57亿 USD0.75%US$49.48-3.55%
Schwab U.S. Small-Cap ETFSCHA442.88万0.02%218.24亿 USD0.03%US$32.66-0.40%
iShares Core S&P Total U.S. Stock Market ETFITOT130.43万0.00%980.88亿 USD0.03%US$169.43-0.14%
Fidelity Nasdaq Composite Index ETFONEQ60.48万0.01%109.4亿 USD0.21%US$107.36-0.42%
Schwab U.S. Broad Market ETFSCHB51.72万0.00%453.77亿 USD0.03%US$29.88-0.10%
T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFTMED19.93万0.60%3296.48万 USD0.44%US$33.6345-0.70%
T. Rowe Price Innovation Leaders ETFTNXT3.55万0.18%1966.95万 USD0.49%US$28.9577-0.68%
T. Rowe Price Small Cap ETFTSEE1.77万0.17%1048.05万 USD0.59%US$24.5453-0.51%ARK Genomic Revolution ETFARKGSchwab U.S. Small-Cap ETFSCHAiShares Core S&P Total U.S. Stock Market ETFITOTFidelity Nasdaq Composite Index ETFONEQSchwab U.S. Broad Market ETFSCHBT. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFTMEDT. Rowe Price Innovation Leaders ETFTNXTT. Rowe Price Small Cap ETFTSEEAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
